Literature DB >> 22530942

Sickle-cell disease and the heart: review of the current literature.

Ersi Voskaridou1, Dimitrios Christoulas, Evangelos Terpos.   

Abstract

Sickle cell disease (SCD) is an inherited chronic haemolytic anaemia whose clinical manifestations arise from the tendency of the haemoglobin to polymerize and deform red blood cells into the characteristic sickle shape due to a single nucleotide change in the β-globin. Vascular occlusion of small and large vessels can lead to chronic damage of multiple organs including brain, lung, bone, kidney, liver, spleen, and retina. However, the extent to which SCD impacts myocardial function is not very clear. Cardiovascular manifestations include both right and left ventricular systolic and diastolic dysfunction, elevated cardiac output, cardiomegaly and myocardial ischaemia. Progressive heart damage from iron overload occurs in patients requiring routine transfusion therapy. Pulmonary hypertension resulting from intravascular haemolysis has also been recognized as a major complication that independently correlates with survival. This review summarizes all available data for the heart complications in SCD to update the physicians for their appearance, diagnostic procedures and possible management.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22530942     DOI: 10.1111/j.1365-2141.2012.09143.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  22 in total

1.  Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease.

Authors:  Erica M Sparkenbaugh; Pichika Chantrathammachart; Kasemsiri Chandarajoti; Nigel Mackman; Nigel S Key; Rafal Pawlinski
Journal:  Blood       Date:  2016-01-27       Impact factor: 22.113

2.  Subclinical left ventricular systolic impairment in steady state young adult patients with sickle-cell anemia.

Authors:  Nadjib Hammoudi; Dimitri Arangalage; Morad Djebbar; Katia Stankovic Stojanovic; Magali Charbonnier; Richard Isnard; Robert Girot; Pierre-Louis Michel; François Lionnet
Journal:  Int J Cardiovasc Imaging       Date:  2014-06-22       Impact factor: 2.357

3.  Abnormalities in aortic properties: a potential link between left ventricular diastolic function and ventricular-aortic coupling in sickle cell disease.

Authors:  Emilie Bollache; Nadjia Kachenoura; Roberto M Lang; Ankit A Desai; Victor Mor-Avi; Amit R Patel
Journal:  Int J Cardiovasc Imaging       Date:  2016-02-23       Impact factor: 2.357

4.  Pulmonary CTA in sickle cell patients: quantitative assessment of enhancement quality.

Authors:  Jeff Jensen; Tony Lin; Elliot K Fishman; Pamela T Johnson
Journal:  Emerg Radiol       Date:  2017-08-11

5.  Carboxy-terminal fragment of fibroblast growth factor 23 induces heart hypertrophy in sickle cell disease.

Authors:  Marie Courbebaisse; Hind Mehel; Camille Petit-Hoang; Jean-Antoine Ribeil; Laurent Sabbah; Véronique Tuloup-Minguez; David Bergerat; Jean-Benoit Arlet; Aurélie Stanislas; Jean-Claude Souberbielle; Hervé Le Clésiau; Rodolphe Fischmeister; Gérard Friedlander; Dominique Prié
Journal:  Haematologica       Date:  2016-10-27       Impact factor: 9.941

6.  Intracardiac or intrapulmonary shunts were present in at least 35% of adults with homozygous sickle cell disease followed in an outpatient clinic.

Authors:  Bryan C Hambley; Rania Abdul Rahman; Maxwell Reback; Mary Ann O'Riordan; Nathan Langer; Robert C Gilkeson; Mahazarin Ginwalla; Jane A Little; Robert Schilz
Journal:  Haematologica       Date:  2018-07-13       Impact factor: 9.941

Review 7.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

8.  Frequency sweep rate dependence on the dielectrophoretic response of polystyrene beads and red blood cells.

Authors:  T N G Adams; K M Leonard; A R Minerick
Journal:  Biomicrofluidics       Date:  2013-12-10       Impact factor: 2.800

9.  Echocardiographic Screening of Cardiovascular Status in Pediatric Sickle Cell Disease.

Authors:  Kiona Y Allen; Shannon Jones; Tannoa Jackson; Grace DeCost; Paul Stephens; Brian D Hanna; Meryl S Cohen; Kim Smith-Whitley; Laura Mercer-Rosa; Shobha S Natarajan
Journal:  Pediatr Cardiol       Date:  2019-09-21       Impact factor: 1.655

10.  Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology.

Authors:  Nihal Bakeer; Jeanne James; Swarnava Roy; Janaka Wansapura; Shiva Kumar Shanmukhappa; John N Lorenz; Hanna Osinska; Kurt Backer; Anne-Cecile Huby; Archana Shrestha; Omar Niss; Robert Fleck; Charles T Quinn; Michael D Taylor; Enkhsaikhan Purevjav; Bruce J Aronow; Jeffrey A Towbin; Punam Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.